What is the address of JOLYMEDICAL?

The registered office of JOLYMEDICAL is located at Chaussée de Jodoigne 73, 1390 Grez-Doiceau.

Is JOLYMEDICAL still active?

Yes. According to the CBE (21 September 2026) JOLYMEDICAL is active, legal situation “Normale toestand”, started on 3 February 2017.

Is JOLYMEDICAL registered on Peppol?

Yes, JOLYMEDICAL is registered on the Peppol network with ID 0208:0670727482.

What is the enterprise number of JOLYMEDICAL?

The enterprise number of JOLYMEDICAL is BE0670727482.

When was JOLYMEDICAL founded?

JOLYMEDICAL was founded on 3 February 2017.

Who are the directors of JOLYMEDICAL?

According to the 2025 annual accounts, the directors of JOLYMEDICAL are: Laurent JOLY.

Is JOLYMEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 February 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JOLYMEDICAL make in 2025?

JOLYMEDICAL posted a profit after taxes of € 41,936 in financial year 2025.

What is the revenue of JOLYMEDICAL?

As a small company, JOLYMEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 89,432.

JOLYMEDICAL (Private Limited) - Grez-Doiceau

Dossier JOLYMEDICAL, printed on 21 September 2026 from databakkes.be/en/0670727482/jolymedical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

JOLYMEDICAL from Grez-Doiceau, company number BE0670727482, closed financial year 2025 with a result of € 41,936 after tax. For that financial year JOLYMEDICAL recorded a gross margin of € 89,432 and equity of € 18,600. Compared with financial year 2024, the result moved from € 46,884 to € 41,936. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 41,936

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,048

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 42,006 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,782

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 51,673

▼ 44% vs 2024

€ 25,594 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,025

▼ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,301

▼ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 92,521 Gross margin 2022: € 92,521 First fiscal year in the series	€ 116,135 Gross margin 2023: € 116,135 ▲ 26% vs 2022 (€ 92,521) Favourable step	€ 99,218 Gross margin 2024: € 99,218 ▼ 15% vs 2023 (€ 116,135) Unfavourable step	€ 89,432 Gross margin 2025: € 89,432 ▼ 10% vs 2024 (€ 99,218) Unfavourable step	▼ 10%
Profit after taxes	€ 37,036 Profit after taxes 2022: € 37,036 First fiscal year in the series	€ 63,189 Profit after taxes 2023: € 63,189 ▲ 71% vs 2022 (€ 37,036) Favourable step	€ 46,884 Profit after taxes 2024: € 46,884 ▼ 26% vs 2023 (€ 63,189) Unfavourable step	€ 41,936 Profit after taxes 2025: € 41,936 ▼ 11% vs 2024 (€ 46,884) Unfavourable step	▼ 11%
Equity	€ 20,847 Equity 2022: € 20,847 First fiscal year in the series	€ 19,036 Equity 2023: € 19,036 ▼ 9% vs 2022 (€ 20,847) Unfavourable step	€ 18,670 Equity 2024: € 18,670 ▼ 2% vs 2023 (€ 19,036) Unfavourable step	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,670) Unfavourable step
Total debts	€ 149,793 Total debts 2022: € 149,793 First fiscal year in the series	€ 149,241 Total debts 2023: € 149,241 Unchanged (€ 149,793) Favourable step	€ 119,187 Total debts 2024: € 119,187 ▼ 20% vs 2023 (€ 149,241) Favourable step	€ 87,192 Total debts 2025: € 87,192 ▼ 27% vs 2024 (€ 119,187) Favourable step	▼ 27%
Cash	€ 9,783 Cash 2022: € 9,783 First fiscal year in the series	€ 10,198 Cash 2023: € 10,198 ▲ 4% vs 2022 (€ 9,783) Favourable step	€ 13,596 Cash 2024: € 13,596 ▲ 33% vs 2023 (€ 10,198) Favourable step	€ 11,048 Cash 2025: € 11,048 ▼ 19% vs 2024 (€ 13,596) Unfavourable step	▼ 19%
Land & buildings	€ 1,505 Land & buildings 2022: € 1,505 First fiscal year in the series	€ 1,397 Land & buildings 2023: € 1,397 ▼ 7% vs 2022 (€ 1,505) Unchanged	€ 1,290 Land & buildings 2024: € 1,290 ▼ 8% vs 2023 (€ 1,397) Unchanged	€ 1,182 Land & buildings 2025: € 1,182 ▼ 8% vs 2024 (€ 1,290) Unchanged	▼ 8%
Retained profit	€ 2,247 Retained profit 2022: € 2,247 First fiscal year in the series	€ 436 Retained profit 2023: € 436 ▼ 81% vs 2022 (€ 2,247) Unfavourable step	€ 70 Retained profit 2024: € 70 ▼ 84% vs 2023 (€ 436) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 70) Unfavourable step	▼ 100%
Dividend	€ 38,000 Dividend 2022: € 38,000 First fiscal year in the series	€ 65,000 Dividend 2023: € 65,000 ▲ 71% vs 2022 (€ 38,000) Unchanged	€ 47,250 Dividend 2024: € 47,250 ▼ 27% vs 2023 (€ 65,000) Unchanged	€ 42,006 Dividend 2025: € 42,006 ▼ 11% vs 2024 (€ 47,250) Unchanged	▼ 11%
Bank debt	€ 140,341 Bank debt 2022: € 140,341 First fiscal year in the series	€ 116,525 Bank debt 2023: € 116,525 ▼ 17% vs 2022 (€ 140,341) Favourable step	€ 92,154 Bank debt 2024: € 92,154 ▼ 21% vs 2023 (€ 116,525) Favourable step	€ 51,673 Bank debt 2025: € 51,673 ▼ 44% vs 2024 (€ 92,154) Favourable step	▼ 44%
Balance sheet total	€ 170,640 Balance sheet total 2022: € 170,640 First fiscal year in the series	€ 168,277 Balance sheet total 2023: € 168,277 ▼ 1% vs 2022 (€ 170,640) Unchanged	€ 137,857 Balance sheet total 2024: € 137,857 ▼ 18% vs 2023 (€ 168,277) Unchanged	€ 105,792 Balance sheet total 2025: € 105,792 ▼ 23% vs 2024 (€ 137,857) Unchanged	▼ 23%

Key figures of JOLYMEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JOLYMEDICAL?

What happened at JOLYMEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 14, 2026 New annual accounts for financial year 2025: profit of € 41,936 (▼ 11% vs 2024). Source: NBB ↗
Feb 3, 2017 Start of the company according to the CBE. KBO

In short

From € 37,036 profit in 2022 to € 41,936 profit in 2025.

Paid € 72,173 in corporate taxes since 2022.

Best year ever: 2023, with € 63,189 profit.

Paid out € 192,256 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at JOLYMEDICAL? We notify you, reason included.

Follow JOLYMEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Laurent JOLY

JOLYMEDICAL

JOLYMO

Behind JOLYMEDICAL is Laurent JOLY. Laurent JOLY is also behind JOLYMO.

See the full network in the app

Directors

According to the 2025 annual accounts

Laurent JOLY

Director

Also active at: JOLYMO

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Jodoigne 73

1390 Grez-Doiceau

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

AxD Consulting

€ 109,151 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0670.727.482
VAT number: BE 0670.727.482
Registered office: Chaussée de Jodoigne 73, 1390 Grez-Doiceau
Names & denominations: JOLYMEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 February 2017
Peppol: Active · Active since 29 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗